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1. Introduction 
Replacement and reconstruction of pathological or absent cartilage within the human body 
has been a clinical challenge for many years. The avascular nature of cartilage tissue in all 
areas of the human body means it has little capacity for regeneration or repair beyond the 
production of functionally inferior fibrocartilage. Cartilage is injured in a number of ways; 
in the joint region, repetitive stress can cause irreparable damage, eventually resulting in 
Osteoarthritis, a debilitating disorder managed only with pain medication or joint 
replacement. A rise in the incidence of cancer has increased the prevalence of tracheal and 
nasal cancers, both frequently requiring radical resection as part of aggressive treatment 
regimes. Congenital disorders, such as Treacher Collins syndrome and Aperts syndrome 
can cause severe malformation of the ear and nose. It is evident that each of these clinical 
scenarios involves extensive damage to crucial skeletal cartilage and it is for these reasons 
that a drive for advancements in cartilage tissue engineering exists. 
Tissue engineering uses principles of cell biology, engineering and medicine to generate 
constructs that can successfully recapitulate the function of native tissues in terms of 
histology, mechanics and morphology. There is a need for a suitable scaffold that can 
provide a 3D environment for cells to proliferate and adhere. Debate still continues over the 
key characteristics needed for the ideal scaffold, but they are likely to differ according to the 
type and location of cartilage to be engineered. Should it be biodegradable/non 
biodegradable, natural/synthetic, and what impact do these features have on the flexibility 
and strength of neocartilage constructs produced? There are many scaffolds that have been 
extensively investigated in cartilage tissue engineering research from natural collagen and 
alginate, to the synthetic Polyhydroxyacids and PEG hydrogels. Nonetheless, despite 
advancements in scaffold design, neocartilage constructs are still mechanically inferior to 
their natural counterparts, and in vivo problems of poor biointegration, and deterioration in 
tissue quality over time limit there translation into clinical use.   
Nanomaterial science has introduced new methods for improving scaffold quality. Scaffolds 
can now be engineered on the nanoscale, using techniques such as electrospinning and 3D 
fibre deposition. Likewise, the incorporation of nanoparticles into polymeric material has 
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allowed the addition of nanoscale features into the matrix structure. Both of these methods 
produce scaffolds that more closely replicate the extra cellular matrix environment found in 
native cartilage. It is hoped that this will increase cellular interaction with the scaffold and 
improve the quality of constructs produced.  
With regards to the cell population to be used for engineering these constructs, there is a 
continued excitement over the possible application of stem cell technology. Stem cells are 
highly replicative and have multi lineage differentiation capacity. The traditional source of 
mesenchymal stem cells (precursor of chondrocytes) is bone marrow and various adjuncts to 
their propagation and differentiation have been explored in detail, such as growth 
hormones, biomaterials and environmental factors such as shear stress and oxygen tension 
that are important for culture techniques and bioreactor design. The discovery of new 
sources of mesenchymal stem cells, such as blood, adipose tissue or the synovium opens up 
a plethora of possibilities for clinical application, where methods of isolation and 
differentiation are being optimized.  
In light of the numerous advancements that have been made in the last decade, this chapter 
aims to give a detailed account of cartilage tissue engineering strategy, looking with 
particular focus at the effect of scaffolds on cell growth, the evolution of stem cell 
technology and the expansion of bioreactor design and application . We will also explore 
how an integration of this revolutionary and innovative bench work can be translated into 
much needed clinical application in the not too distant future.   
2. Cartilage in the human body 
2.1 Cartilage tissue biology 
Cartilage is a flexible connective tissue found in many areas of the human body, including 
the joints, ribs, nose, ear, trachea and intervertebral discs (Fig 1). In these regions cartilage 
can act as structural support, maintain shape or absorb shock during physical exercise. 
Unlike most other connective tissues, cartilage is largely avascular leading to hypoxic 
environments that limit the rate of cellular growth and tissue regeneration (115; 116). This in 
turn limits the capacity of cartilage to repair itself in the event of damage. The main cellular 
component of cartilage are chondrocytes, highly specialized cells that lie within spaces 
called lacunae and secrete the extracellular matrix (ECM) of cartilage . As with most 
connective tissues, the ECM of cartilage consists of a meshwork of macromolecules 
including collagens, elastin, glycoproteins and proteoglycans, each of which is present in 
varying amounts, depending on the type and function of cartilage. There are several cell 
surface receptors that allow chondrocytes to bind these proteins including the integrins, 
CD44, and the proteoglycan family of receptors e.g. syndecan (144).  
The three types of cartilage are hyaline, elastic and fibrocartilage. Hyaline is the most 
abundant type, white-blue in colour and macroscopically smooth on its surface. It is present 
on the articular surfaces of joints and in the nasal septum. Hyaline cartilage is covered 
externally by a fibrous membrane known as the perichondrium, and in the joint especially, it 
is diffusion from the synovial fluid that provides this tissue with nutrition. It is rich in 
collagen type II, which forms a meshwork that encases giant aggregates of proteoglycans 
(Proteins with glycosaminoglycan (GAG) side chains e.g. aggrecan, biglycan, decorin in the 
extracellular matrix; syndecan, CD44 and fibroglycan as cell surface receptors; serglycan in 
intracellular tissues) (20; 21). These GAG side chains, keratan and chondroitin sulphate are 
able to retain water. Cyclical pressures from joint loading are crucial for normal hyaline 
cartilage function, and encourage the passage of water and nutrients between cartilage and 
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synovial fluid. Elastic cartilage however, is more flexible, due to its rich elastin fibre content 
that is woven into a collagen mesh (20; 21). Elastin is an insoluble protein polymer that 
when cross linked with desmosine and isodesmosine make up the elastin fibres themselves. 
This type of cartilage is also surrounded by perichondrium and is more commonly found in 
the pinna, Eustachian tube, larynx and epiglottis, providing crucial structural support and 
flexibility. The third type of cartilage is fibrocartilage, which contains abundant thick 
collagen type I in addition to type II, that are interlaced into a mesh work of longitudinal 
and circumferential fibres (20; 21). These collagen bundles impart a great ability for this type 
of cartilage to withstand high tensile stresses. Fibrocartilage is usually found with the 
intervertebral discs, sacroiliac joints, pubic symphysis and costochondral joints.  
 
 
Fig. 1. A diagrammatic representation of cartilaginous regions in the human body 
2.2 Development of cartilage  
Central to effective tissue engineering practice is the understanding of tissue origin and 
development. This is based on the widely accepted hypothesis that natural tissue 
regeneration recapitulates developmental processes (118); hence embryological study can 
give an insight into the regulatory processes and patterns that govern tissue type and 
function, in addition to forming a foundation for understanding the degeneration and 
damage seen in tissues of the human body. We can only give a brief outline of the 
development of cartilaginous tissue specifically, however interested parties are advised to 
consult specific reviews (17; 70; 121) and books that devote entire chapters to this topic.  
Costochondral cartilage 
CARTILAGE IN THE HUMAN BODY 
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One of the epicentres of skeletal cartilage development is the growth plate which produces 
long bones via the cartilage template in a process known as endochondral ossification. It is 
important to note that this process is specific to the articular regions of bones and is 
followed by the eventual replacement by bony tissue. A milieu of hormones and paracrine 
factors govern a complex interplay of chondrocyte proliferation and differentiation, and the 
process can be divided into five stages, with the first three mainly being crucial for cartilage 
formation (144). Mesenchymal stem cells (MSCs) are first committed to becoming 
chondrocytes by paracrine factors that induce the expression of key transcription factors Pax 
1 + scleraxis, which in turn activate cartilage specific genes. During the second stage, the 
committed MSCs condense into compact nodules and differentiate into chondrocytes. 
Chondrocytes then proliferate rapidly during the third stage, increase their cytoplasmic 
contents and secrete large amounts cartilage specific ECM. Their volume increases 5-10 fold, 
proliferation slows and they are known as hypertrophic. After this stage, the expression profile 
of the cells change and collagen type X and fibronectin are secreted, enabling mineralization 
by calcium carbonate and osteoblast infiltration to make bone. Vascular infiltration leads the 
way to terminal differentiation and bone development, resulting in chondrocyte apoptosis and 
osteoblastic differentiation. Facial cartilage development is very different, as it is 
embryologically derived from the cranial neural crest cells that originate from the anterior 
hindbrain. These cells migrate to specific locations and differentiate under the instruction of an 
array of Hox genes, the complexities of which are outside the scope of this chapter.  
2.3 Clinical need for cartilage  
Due to the limited self healing capacity of human cartilage, the repair of defects caused by 
degenerative joint diseases, cancer or trauma gives rise to a challenging clinical problem. In 
the joint region in particular, lesions of the articular cartilage are frequently associated with 
debilitating pain and reduced functionality. If not successfully treated long term disability 
can only be averted by total replacement of the joint. Damage to facial cartilaginous 
structures such as the nose or ear are only resolved with a prosthesis or autologous 
transplantation surgery that results in the formation of a donor site and frequently requires 
a number of revision surgeries. Large scale damage to the trachea has even less options for 
reconstruction with stents and tracheotomy tubes being the mainstay of treatment.    
Cartilage regeneration has always been a key therapeutic target for treating articular 
cartilage damage in particular. Popular marrow stimulating techniques using micro-fracture 
or subchondral drilling of the bone have been developed to encourage the invasion of 
mesenchymal progenitor cells (MPC) into the affected site for spontaneous cartilage repair 
(94; 109). Unfortunately the outcome of such techniques varies greatly due to the lack of 
biological instructions for the MPCs to follow. This results in the formation of fibrocartilage 
which compared with hyaline tissue, has reduced durability and functionality (87; 140). The 
later invention of cell based therapies such as Autologous Chondrocyte Implantation (ACI) 
provided an important breakthrough treatment of articular cartilage damage and paved the 
way perhaps for more complex tissue engineering approaches with matrix assisted ACI 
introduced later on (16). ACI involves harvesting and propagating a population of 
autologous mature articular chondrocytes in vitro and re-introducing them into the defect 
site in cell suspension or in a supported matrix. They are then expected to lay down ECM to 
repair the site of injury (12; 102). Clinically the results of such procedures are good as they 
appear to provide symptomatic relief for patients. However, histologically the tissue 
produced is far inferior to native hyaline, being fibrotic in nature, again with limited 
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functionality and durability (19; 66; 120; 141). Further evaluations of such techniques has 
evidenced a strong correlation between the quality of tissue produced and the symptomatic 
relief of the patient from swelling and pain, once again highlighting the importance of tissue 
quality in cartilage regeneration. It can be postulated that these clinical breakthroughs 
buttressed the drive for advancements in cartilage tissue engineering technique. 
It is also essential to note that the desired characteristics of engineered cartilage depend 
heavily on the site to be reconstructed. For instance, in tracheal constructs mechanical 
integrity, strength, flexibility and durability are all crucial for function, whereas in the facial 
region the aesthetic properties of the constructs may be equally as important. Taking the 
specific requirements of the tissue to be regenerated into consideration informs the tissue 
engineering strategy and the expected out comes of such undertakings.  
2.4 Tissue engineering cartilage  
Cartilage tissue engineering paradigm is based on the isolation of chondrocytes/ 
chondrocyte precursors from a tissue biopsy, expanding the cell number in culture, seeding 
them onto 3D scaffold, incubating for a period of time before placing the construct inside a 
patient. Many studies over the last decades have demonstrated that animal cells, when 
utilised in this way can produce tissues approaching the biomechanical and histological 
properties of native cartilage, even after implantation in vivo (3; 8; 24; 48; 58; 64; 77; 99; 110; 
113; 152). However challenges do arise regarding the translation of such academic success 
into the clinical scenario. Challenges include isolating and propagating primary human 
cells, gaining relevant and reproducible construct morphology and size and ensuring good 
durability of the construct in vivo. Cell phenotype regulation, in vitro expansion of cell 
numbers, scaffold design and suitability, bioreactor design are all crucial components of the 
tissue engineering process that need to be optimized to advance cartilage tissue engineering 
from a mere academic prologue, into a clinical reality and success. These challenges will be 
discussed at length in the rest of this chapter. 
 
 
Fig. 2. A diagrammatic outline of tissue engineering strategy in cartilage tissue engineering 
for articular joint repair (an example of clinical usage) 
3. Stem cell technology 
Stem cells are unspecialised cells with a very high replication capacity. For cartilage 
regeneration, mesenchymal stem cells are the cell type of choice as they are multipotent 
stem cells, capable of differentiating into a number of lineages of the musculoskeletal 
MSC-rich Autologous 
Bone marrow aspirate
1. Isolate MSCs 2. Grow and differentiate 
MSCs into chondrocytes 
3. Seed onto optimized 
scaffold matrix 
Proliferate and differentiate 
into chondrocytes Culture in Bioreactor
4. Implant into Patient 
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system, including osteoblasts (bone cells), chondrocytes (cartilage cells) and adipocytes (fat 
cells). Although not immortal, these cells are capable of expanding through many passages 
in culture while retaining their growth and multi-lineage potential. 
MSCs can originate from various tissues including the bone marrow (11), skeletal muscle, 
adipose (106; 159) synovium (134), the embryo and periosteum. The optimal cell source for 
cartilage tissue engineering is still being identified. When selecting an ideal cell source, it is 
important to achieve a number of criteria, including: (i) easy access to/harvesting of the 
source of MSCs, (ii) extensive self-renewal or expansion capability of the cells (to generate 
sufficient quantities of cells for large scale tissue engineering, (iii) the ability to readily 
differentiate into the chondrocytic lineage when induced, and (iv) a lack of or minimal 
immunogenicity or ‘tumourigenic’ tendencies. The two most commonly used MSC 
sources are adipose tissue and bone marrow. Unlike other sources such as embryonic 
tissue, there are few ethical issues associated with harvesting and using these tissues in 
research and development. Additionally, bone marrow MSCs (BMSCs) and adipose 
derived (ADMSCs) are relatively easy to source compared with synovium-derived- or 
periostium-derived MSCs.  
Interestingly, bone marrow is the only organ in which at least two types of stem cells exist; 
hematopoietic and mesenchymal stem cells (137). The MSCs are found arrayed around the 
central sinus in the bone marrow. The cells can be isolated from the marrow using 
standardised techniques and expanded in culture through many generations, while 
retaining their capacity to differentiate along these pathways when exposed to appropriate 
culture conditions. Adipose tissue is an abundant, readily available source of MSCs. The 
cells can be isolated from fat that has been excised or ‘liposuctioned’ (lipoaspirate). There 
are advantages and disadvantages to both techniques. Anecdotally, it is thought that excised 
fat provides a higher yield of MSCs compared with lipoaspirate. This is due minimal 
mechancal impact upon cell membranes, which would ordinarily cause cell rupture, during 
the isolation process. Conversely, lipoaspirate is accessible without creating a large donor 
site defect, a major reason for pursuing tissue engineering methods at the outset. Some 
studies have compared adipose-derived MSCs and bone marrow-derived MSC (107; 122) 
and found that both BMSCs and ADASCs are capable of chondrogenic differentiation. There 
is some debate over which is the superior cell source, with numerous papers highlighting 
each source at optimum (107). 
Mesenchymal stem cells can be identified using a number of methods. These include i) 
examination of cell morphology, ii) FACS (fluorescence activated cell sorting) analysis to 
detect the expression of MSC specific markers and iii) proving their differentiation capacity 
by differentiating the cells into a number of lineages, namely; osteoblastic, adipocytic, and 
chondrocytic. For FACS analysis, the presence of MSC-specific cell surface proteins such as 
the following are sought; CD 105 (SH2), CD 90 (THY1) and CD 73 (SH3/4). Similarly, 
negative markers are used to mark and remove cells expressing cell surface proteins not 
typically seen on MSCs, such as CD 45, CD 34, and CD 14 (9).  
3.1 Stem cell differentiation to chondrocytes 
Chondrogenesis is the term used to describe the process by which a stem cell is 
differentiated into a mature chondrocyte and is one of the earliest morphogenetic events of 
embryonic development (112). The stages where introduced earlier in the section on 
cartilage tissue biology. They include: MSC condensation, the rise of chondroprogenitors, 
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chondrogenesis, terminal differentiation of progenitor cells and in skeletal development 
ossification (29).  
 
Cell Type 
Factors 
ECM 
Proteins 
 
Chondroprogenitors MSCs Chondroblasts Chondrocytes Hypertrophic 
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SOX 9 
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SOX 9 
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SOX 9 
RUNX2 
 
FGF2 
TGF-β 
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VEGF 
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Fig. 3. Schematic diagram of the stages of chondrogenesis, the main growth factors involved 
in each stage and the accompanying alterations in ECM. (Adapted from Vinatier C. 2009  
(144)) 
Condensation is directed by cell-cell and cell-matrix interactions as well as secreted factors 
interacting with their related receptors. Prior to condensation, the prechondrocytic MSCs 
secrete an extracellular matrix (ECM) which is rich in hyaluronan and collagen type I that 
prevents intimate cell-cell interaction (60). When condensation is initiated, there is an 
increase in hyaluronidase activity, thus causing a decrease in hyaluronan in the ECM. It is 
thought that hyaluronan facilitates cell movement, therefore, the increase in hylauronidase 
and subsequent decrease in hyaluronan allows for close cell-cell interactions. The 
establishment of the cell-cell interactions is thought to be involved in triggering one or more 
of the signal transduction pathways that initiate chondrogenic differentiation. Cell adhesion 
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molecules: N-cadherin (neural cadherin) and N-CAM (neural cell adhesion molecule) are 
also expressed in the condensing mesenchyme, but disappear in the differentiated cartilage, 
and later can be found only in the perichondrium. Perturbing the function of N-cadherin or 
N-CAM causes a reduction or alterations in chondrogenesis both in vitro and in vivo, which 
further evidences a role for these cell adhesion molecules in mediating the mesenchymal 
condensation step (46; 60). 
As mentioned earlier, cell-matrix interactions also play an important role in mesenchymal 
cell condensation. Fibronectin is a component of the ECM which has the ability to regulate 
N-CAM. TGF-ǃ1, one of the earliest signals in chondrogenic condensation, stimulates the 
synthesis of fibronectin. The expression of fibronectin is increased in areas of condensation 
and decreased as cytodifferentiation proceeds. Syndecan binds to fibronectin and down-
regulates N-CAM thereby setting the condensation boundaries. One study showed that 
fibronectin mRNA undergoes alternative splicing during chondrogenesis. The isoform 
containing exon EIIIA is present during condensation but disappears once differentiation 
begins. This suggests that this isoform switching is important for cytodifferentiation to 
occur. A later study by the same group determined that the function of the fibronectin EIIIA 
exon seems to regulate mesenchymal cell spreading, therefore permitting and/or promoting 
adequate cell-cell interaction to take place during the condensation phase of chondrogenesis 
(46). 
The differentiation of chondroprogenitors is characterized by the deposition of cartilage 
matrix containing collagens II, IX, XI and aggrecan. SOX9 is one of the earliest markers 
expressed in cells undergoing condensations. It is required for the expression of the type II 
collagen gene (Col2a1) and other cartilage-specific matrix proteins, including Col11a2 and 
CD-RAP prior to other matrix deposition in the cartilage anlagen. Two other Sox family 
members L-Sox5 and Sox6, are not expressed in early mesenchymal condensations, but are 
co-expressed with Sox 9 during chondrocyte differentiation.  Figure 2 outlines the stages of 
chondrogenesis and the accompanying alterations to the ECM (46; 60). 
3.2 Inducing chondrogenesis 
3.2.1 Biochemical stimuli for cartilage tissue engineering 
Specific biomolecules are essential for cartilage tissue engineering. The role of these 
biomolecules is primarily to induce chondrogenesis and to maintain the chondrocyte 
phenotype. There are five main families of growth factors involved in chondrogenic 
differentiation. These are: the transforming growth factor-ǃ super-family (TGFǃ), the 
fibroblast growth factor family (FGF), the insulin-like growth factor family (IGF), the 
wingless family (Wnt) and the hedgehog family(HH) (144). Below is a brief introduction to 
each growth family. However, for a more detailed description, the following references are 
recommended (46; 144). Figure 3 outlines the sequence in which the transcription factors are 
involved in each stage of chondrogenesis. 
The transforming growth factor beta super-family is a family of proteins which have been 
shown to play a huge role in cartilage formation (11). Members include TGF-ǃ, bone 
morphogenetic proteins (BMPs), inhibins and activins.  All members have been shown to 
regulate cell growth, differentiation and apoptosis of a large number of different cell types 
including osteoblasts, chondrocytes, neural and epithelial cells. TGF-ǃ is a secreted protein 
and exists in five isoforms TGF- ǃ1-5. TFG- ǃ 1,2 and 3 are thought to stimulate 
proteoglycans and type II collagen synthesis in chondrocytes as well as to induce 
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chondrogenic differentiation of MSCs (144) . Studies have also shown that TGF- ǃ isoforms 
differ in their effects on various cell types. For example, TGF- ǃ1 has been shown to be 
responsible for the initial cell-cell interactions between condensing progenitor cells and 
TGF-ǃ2 mediates hypertrophic differentiation (32).  
BMPs are also members of the TGF-ǃ super-family and comprise of a group of 20 proteins 
each one playing an important role in chondrogenesis and osteogenesis during skeletal 
development. BMP -2,-4,-6,-7 and -13 have all proven their ability to stimulate 
chondrogenesis in MSCs (144) .  BMP2 in particular, has been found to be expressed in the 
condensing mesenchyme of the developing limb (101). It regulates chondrogenic 
development of mesenchymal progenitors (25) as well as stimulates the synthesis of 
chondrocyte matrix components by articular cartilage in vitro. Even combinations of many 
growth factors have been to enhance chondrogenesis, for example, BMP-2 with TGF-ǃ3 and 
BMP-6 with TGF-ǃ3 have been proven to stimulate chondrogenic differentiation and result 
in chondrogenic lineage development (73; 127). 
The FGF family is a group of growth factors consisting of 22 members. Most FGFs are 
secreted, except for FGF1, 2 and FGF 11 and 14 (144). Signalling by FGF18 and FGF receptor 
3 have demonstrated regulation, proliferation, differentiation and matrix production of 
articular cartilage and growth plate chondrocytes in vivo and in vitro (45). 
The IGF family is a group of proteins which have a high similarity to insulin. IGF-1 has the 
ability to mediate chondrogenesis by increasing proteoglycan and collagen type II 
production (144). Combining TGF-ǃ3 and IGF-1, has been shown to enhance chondrogenic 
induction (72). One study examined the effect that IGF-1 has on the chondrogenesis of bone 
marrow MSCs in the presence and absence of TGF-ǃ signalling. It showed that IGF-1 could 
modulate MSC chondrogenesis by stimulating proliferation, regulating cell apoptosis and 
inducing expression of chondrocyte markers. In addition, it proved that the 
chondroinductive actions of IGF-1 were equally potent to TGF-ǃ1 and independent from the 
TGF-beta signalling (98). Another similar study investigated the effects of IGF-1 on TGF-ǃ1 
induced chondrogenesis. It was found that the combination of IGF-1 and TGF-ǃ1 produced 
higher amounts of glycosaminoglycan than TGF-beta1 alone at 8 weeks (124). 
3.2.2 Mechanotransduction in cartilage tissue engineering 
In vivo, articular cartilage experiences a variety of stresses and strains on a daily bases. 
Thus, many groups have extensively researched into the various mechanical stimulation 
methods for enhancing chondrogenic differentiation and cartilage tissue engineering (67; 68; 
135).Examples of the types of mechanical stimuli examined include: hydrostatic pressure (4), 
cyclic mechanical compression (4), shear stress (139; 143), pulsed ultrasound (130) and 
dynamic compressive strain (23). 
It has been found that exposing differentiating MSCs to various mechanical stimuli results 
in a shift in the types of protein expressed during chondrogenesis. For example, the 
application of cyclic, mechanical compression has been shown to result in an increase in 
proteoglycan and collagen contents as well as a higher amount of proteoglycan-rich, 
extracellular matrix production. Similarly, the application of shear stress by perfusion to 
differentiating BM-MSCs results in an enhanced ECM deposition and an increased collagen 
type II production (143). Low intensity pulsed ultrasound treated cell scaffold constructs 
show a significant increase of chondrogenic marker gene expression and extracellular matrix 
deposition in differentiating human BM-MSCs (130).  
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Collectively, the research shows that MSCs are mechanically sensitive and the chondrogenic 
differentiation can be modulated and enhanced by mechanical stimulation. 
4. Biomaterials  
It is well established that cells reside, proliferate and differentiate inside a complex 3-
dimensional (3D) ECM environment. In cartilage, chondrocytes are surrounded by a highly 
hydrated matrix of proteins which informs many of their phenotypic states. For example, 
research has shown that isolated chondrocytes will loose their differentiated phenotypes if 
cultured in 2-dimension (42). These chondrocytes display a shift towards a fibroblastic 
phenotype, evident on protein assays and histological evaluations. Type I collagen 
expression is increased and the typical rounded morphology of the chondrocyte becomes 
spindle in shape (128). This process has been shown to be reversible upon relocation to 3D 
matrix environments such as pellet and micro-mass culture systems, which mimic the high 
cell density phenomenon seen during MSC condensation, a crucial stage of cartilage 
development (47; 74; 92).  
It is in light of this that biomaterials have been proposed as engineered 3D environments in 
which chondrocytes can reside. For years, material scientists along with cell biologists have 
worked to optimize the tissue engineering characteristics of various biomaterials. There are 
a number of characteristics that are thought to be necessary for general tissue engineering 
attempts. These include a need for biomaterials to allow adequate cell adhesion and 
migration, with subsequent proliferation and differentiation. The overall architecture of the 
scaffold should guide and frame tissue formation, whilst providing mechanical support akin 
to that of native tissue. The scaffold should be porous, as porosity is thought to be crucial in 
maintaining the phenotype of the differentiated chondrocytes, considering their preference 
for 3D environments. It would also allow for mass transfer of nutrients and waste products. 
The scaffold should also be biocompatible with the ability to integrate into surrounding 
native tissue. 
Biomaterial scaffolds can be broadly divided into natural and synthetic scaffolds. In this 
section we will give a brief overview of existing natural and synthetic scaffolds used for 
cartilage tissue engineering research, focusing on the regulatory influence these scaffolds 
have on cell behaviour and the potential application of nanomaterial science to this research.  
4.1 Natural  
Natural materials used as bioactive scaffolds include agarose, alginate, collagen, Hyaluronic 
acid and acellular cartilage matrix (Table.1). The potential for clinical use of these scaffold 
matrices is hampered however by poor mechanical strength and flexibility, in addition to a 
potential for disease transfer and immune system reactivity if allogenically sourced. Their 
biochemical make-up leaves them prone also to host-related degradations. 
Agarose: a linear polysaccharide consisting of repeating units of agarobiose, derived from 
Asian seaweeds and capable of supporting the chondrogenic phenotype. Its ability to form 
hydrogels allows it to encapsulate chondrocytes providing a 3D matrix for their growth and 
development. A group in Germany performed allograft transplants of chondrocytes in 
agarose gel into osteochondral defects in the knee of rabbits. There we no graft versus host 
rejections, and after 18 months, 47% of grafts had morphologically stable hyaline –like 
cartilage (117).    
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Ref. Fabrication Method Cells Source Outcome 
Natural 
ALGINATE 
(49) Chondrocyt
es in 
suspension 
with 2% 
sodium-
alginate 
In vivo; 500µl of 
suspension injected 
subcutaneously into 
dorsa of nude mice. 
Calcium chloride then 
injected into this area 
to stimulate cross 
linking of the scaffold. 
Cartilage harvested 
from 14 to 38 weeks 
Human nasal 
septal 
chondrocytes 
Gross analysis showed that 14/15 
constructs resembled native 
human cartilage. 6 of the explants 
had histologically homogenous 
resemblance to native cartilage. 
The neo-constructs stained 
positively for Col II.  
(97) 3D alginate 
scaffold 
prepared by 
freeze 
drying 
In vitro; Cells were 
cultured in the 
alginate for 1-4 weeks 
in a bioreactor 
Porcine 
articular 
chondrocytes 
RT-PCR analysis showed the cells 
maintained their differentiated 
phenotype for up to 4 weeks. The 
cell also proliferated increasing 
from 5 x 105 cells to 3 x 107.  
(151) 3D alginate 
gels 
In vitro; cell/gel 
constructs were 
cultured for 0, 6, 12, 
18 and 24 days 
Human MSCs Results of qRT-PCR analysis 
provided a temporal analysis for 
marker expression during 
chondrogenesis. Stage I (days 0–
6): Col I and VI, Sox 4, and BMP-
2. Stage II (days 6–12): Cartilage 
oligomeric matrix protein, 
HAPLN1, Col XI, and Sox 9. Stage 
III (days 12 -18): Matrilin 3, Ihh, 
Hbx 7, chondroadherin, and WNT 
11. Stage IV (days 18–24): 
aggrecan, collagen IX, II, and X, 
osteocalcin, fibromodulin, PTHrP 
and alkaline phosphatise. 
(91) Alginate gel 
layer 
In vitro; To evaluate 
the effect of low-
intensity ultrasound 
(LIUS) on cell 
viability during 
chondrogenic 
differentiation 
Human MSCs When the cell/alginate construct 
was cultured with TGF-ǃ1, cell 
viability decreased. However, 
addition of LIUS enhanced 
viability and inhibited apoptosis 
under the same conditions. 
Demonstrated by the expression 
profiles of apoptosis genes, p53, 
bax and bcl-2. 
(30) Hydrogel In vitro; Chondrocytes 
were seeded onto 
alginate after 1, 2 and 
3 passages in a 
monolayer.  
Human nasal 
septal 
chondrocytes 
Alginate stimulated GAG and Col 
I deposition supporting the 
chondrocytic phenotype. Results 
did not also support other research 
showing that culture with alginate 
beads can redifferentiate cells. 
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CHITOSAN  
(114) Fibrous 
scaffold vs. 
sponge 
In vitro; constructs 
analysed 3 days, 10 
days and 21 days 
after cell seeding 
Mouse BMSC 
line 
At 10 and 21 days the cells were 
embedded but did not aggregate, 
with fibrous scaffolds containing 
more ECM. The cells had a round 
morphology. Histology revealed 
cell and ECM distribution was not 
homogenous. mRNA expression 
for Col II was 3 times greater for 
the fibrous scaffold compared 
with the sponge at 21 days 
(22) Chitosan 
scaffold and 
Chitosan 
microspher
es 
In vitro; Scaffold and 
microspheres used 
asTGF-ǃ1 carrier to 
see the effect of this 
growth factor on 
chondrogenic 
potential 
Rabbit 
articular 
chondrocytes 
Encapsulation efficiency of TGF-
ǃ1 was 90.1%. TGF-ǃ1 was 
released from chitosan in a 
multiphase fashion. TGF-ǃ1 
loaded microspheres significantly 
improved cell proliferation rate 
and Col II production, compared 
with controls with no 
microspheres or controlled TGF-
ǃ1 release.  
(61) Chitosan 
scaffold 
synthesized 
via freeze 
drying  
In vitro; cells seeded 
on to chitosan of 
varying porosity; 
<10µm, 10-50µm and 
70-120µm. Cultured 
for 28days in a 
rotating bioreactor 
Porcine 
articular 
chondrocytes 
Chitosan scaffolds remained 
intact compar4ed with the 
positive control PGA. However 
cartilage specific DNA levels and 
GAG were lower in the Chitosan 
groups compared with PGA. 
Chitosan also had the largest 
pores, with more Chondrocytes, 
but on histological analysis, the 
composition of cartilage produced 
on PGA resembled the structure 
of native cartilage more than 
chitosan constructs. 
COLLAGEN  
(38) PLGA mesh 
and 
Collagen 
sponge 
In vitro; hybrid disks 
of PLGA/Collagen 
scaffold with different 
structures. In vivo; 
week old cultured 
constructs implanted 
into dorsa of athymic 
nude mice and 
harvested after 2, 4 
and 8 weeks 
Bovine 
articular 
chondrocytes 
Homogenous cell distribution 
with natural chondrocyte 
morphology. Abundant ECM 
production. Levels of GAG and 
Collagen II DNA, and aggrecan 
mRNA increased on the scaffolds 
with more collagen (semi, 
collagen on one side of PLGA and 
sandwich, collagen on both sides). 
Semi and sandwich compared 
with natural articular cartilage, 
had a Young’s modulus of 54.8% 
and 49.3% respectively. 76.8% and 
62.7% in stiffness.  
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(156) Hydrogel In vivo: comparison of 
collagen hydrogel 
and collagen-alginate 
hydrogel. Gel injected 
subcutaneously into 
rabbit backs. 
BM-MSC Homogenous distribution of cells 
with chondrocyte characteristics 
demonstrated the chondrogenic 
differentiation of BM-MSCs. Both 
collagen hydrogel and collagen 
alginate hydrogel may induce 
chondrogenesis. Expression 
profile of cartilage specific genes 
differed between collagen 
hydrogel and collagen alginate, 
indicating that induction of 
chondrogenesis is materials 
dependent. 
(153) 3D collagen 
sponged 
In vitro; Cells seeded 
onto collagen sponges 
and cultured in either 
standard or serum 
free culture 
conditions for 1, 2 and 
4 weeks 
Bovine 
articular 
chondrocytes 
Overall chondrogenesis in serum 
free culture (Nutridoma 
replacement) was equivalent or 
better than control cultures in 
serum. Insulin-
transferrinselenium (ITS+3) 
serum replacement cultures were 
poor due to decreased cell 
viability. The porous 3D collagen 
sponges were able to maintain 
chondrocyte viability, shape, and 
synthetic activity with evidence 
from quantitative assays for 
cartilage-specific gene expression 
and biochemical measures of 
chondrogenesis. 
FIBRIN 
(83) Fibrin gel In vivo: ACI on 30 
patients using 
minimally invasive 
injection techniques. 
Mix of fibrin gel and 
chondrocytes.  
Autologous 
adult 
chondrocytes 
Patients evaluated 24 months post 
operatively using the Cincinnati 
knee ligament rating scores, for 
which 10 patients had excellent 
result, 17 with good results, two 
fair and one poor result. Further 
arthroscopy in 10 patients 
demonstrated good fill and 
integration in grafted areas.  
(131) PLGA/Fibri
n hybrid 
scaffold  
In vitro; PLGA 
scaffold soaked in 
chondrocyte-fibrin 
suspension 
(polymerized by 
thrombin CaCl2 
solution), Constructs 
were cultured for a 
maximum of 21 days. 
Rabbit 
articular 
chondrocytes 
Cell proliferation increased 
steadily until day 14, but declined 
by day 21. Cartilage formation 
evident at day 14, confirmed by 
the presence of cartilaginous cells 
embedded in basophilic ECM 
filled lacunae. Proteoglycan and 
GAG presence was confirmed. 
Suppression of the cart 
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dedifferentiation marker Col 1 
observed after 2 and 3 weeks in 
culture. sGAG production greater 
in fibrin/PLGA compared with 
PLGA control.  
(28) PLGA/Fibri
n hybrid 
scaffold 
In vivo; PLGA scaffold 
soaked in 
chondrocyte-fibrin 
suspension 
(polymerized by 
thrombin CaCl2 
solution) and 
constructs implanted 
subcutaneously into 
dorsum of nude mice 
for 4 weeks after 
culture for 3 weeks. 
Analysis performed 
at 1, 2 and 4 weeks.  
Rabbit 
articular 
chondrocytes 
Constructs maintained their 
shape and there was no 
significant difference between 
fibrin/PLGA and control PLGA. 
All exhibited smooth cartilage like 
properties 1, 2 and 4 weeks after 
implantation. Presence of 
proteoglycans and GAG was 
confirmed. The constructs were 
also strongly positive for Col II. 
Notably, sGAG production was 
greater on fibrin/PLGA scaffold 
than the control. Overall, both 
fibrin/PLGA and PLA showed 
comparable potential in 
sustaining the chondrogenic 
phenotype. 
HYALURONIC ACID(HA) 
(33) ***Hyaff®-
11, 
biodegrada
ble 
polymer, 
nonwoven 
mesh 
In vitro; Chondrocytes 
were harvested from 
OA patients and 
seeded onto Hyaff®. 
Constructs remained 
in culture for 28 days, 
analysed on day 0, 7, 
14, 21 and 28.  
Human 
Autologous 
chondrocytes 
Viability and proliferation of OA 
chondrocytes similar to cells from 
normal subjects. 
Immunohistochemistry showed 
no signs of ageing or degeneration 
in cartilage produced by OA cells. 
The experimental groups and 
controls both had significantly 
raised Col II, Sox 9 and aggrecan. 
Suggests OA cells benefit from 
the HA rich environment. 
(154) Hydrogel 
(in vitro), 
beads(in 
vivo) 
In vitro and In vivo; 
implanted into nude 
mice. Constructs were 
cultured in vitro for 2 
weeks prior to 
implantation. 
Constructs remained 
implanted for 2 
weeks. 
Human MSC Both in vitro and in vivo cultures 
of MSC-laden HA hydrogels 
enabled chondrogenesis. This was 
measured by the early gene 
expression and production of 
cartilage specific matrix proteins 
(aggrecan, Col II). HA hydrogels 
were compared to relatively inert 
poly(ethylene glycol) (PEG) 
hydrogels, and showed enhanced 
expression of cartilage specific 
markers 
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(107) HA 
immobilize
d on surface 
of PLGA 
scaffold 
In vitro; 
biodegradable 
macroporous PLGA 
scaffolds chemically 
conjugated to the 
surface exposed 
amine groups of the 
PLGA. Incubation 
times varied for each 
assay. 
Bovine 
articular 
chondrocytes 
Enhanced cellular attachment was 
observed compared with PLGA 
controls. GAG and total Col 
synthesis was significantly 
increased for HA/PLGA 
compared to the control. The 
HA/PLGA constructs exhibited 
morphological characteristics of 
cartilage and had cartilage 
specific Col II expression. 
Synthetic 
PLGA- Poly(lactic-co-glycolic) acid 
(107) PLGA 
scaffolds 
In vivo: PLGA 
scaffolds were seeded 
with AD-MSC, 
cultured in TGFǃ1 
containing medium 
for 3 weeks, prior to 
implantation in the 
subcutaneous pockets 
of nude mice for 8 
weeks.  
Human AD-
MSC 
RT-PCR demonstrated the 
increased expression profiles of 
chondrospecific marker mRNA, 
compared with control samples 
after 3 weeks in vitro and 8 weeks 
in vivo.  
(150) HA 
modified 
porous 
PLGA 
scaffold 
In vitro; cells seeded 
onto HA/PLGA 
scaffolds and cultured 
for a total of 5 days. 
Human AD-
MSC 
The AD-MSC cultured in HA 
coated wells showed enhanced 
expression of cartilage specific 
mRNA. HA-modified PLGA did 
not affect cell adherence and 
viability, but did enhance gene 
expression after 1, 3 and 5 days in 
culture. GAG and Col I 
production enhanced after 4 
weeks in culture compared with 
PLGA control.  
(10) PLGA 
scaffolds 
In vivo; cells were pre-
cultured on poly-
HEMA coated dish, 
then seeded onto 
PLGA. The construct 
was implanted into 
the subcutaneous 
pockets of nude mice 
for 16 weeks. 
Chondrocytes Macroscopic signs of neo cartilage 
formation appeared at 8 weeks, 
and completed by 16 weeks. All 
constructs showed viable 
chondrocytes with normal 
lacunae and ECM. They stained 
positively for Col II. Control was 
a cell-free scaffold implanted into 
the other side of the dorsum on 
the same mouse.  
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(75) PLGA 
microspher
es 
In vivo; PLGA 
microsphere seeded 
with rabbit 
Chondrocytes 
injected 
subcutaneously into 
dorsa of athymic 
female mice 
Autologous 
rabbit 
Chondrocytes
The PLGA microsphere permitted 
cell adhesion. 4 and 9 weeks post-
implantation there was 
macroscopic and histological 
evidence of cartilage formation on 
the seeded PLGA microsphere 
compared with nothing on the 
PLGA and chondrocyte controls. 
(142) PLGA 
porous 
scaffold 
disks 
In vivo; MSC seeded 
PLGA scaffold disks 
implanted into 36 
week old Japanese 
white rabbits. 
Constructs were 
harvested after 4 and 
12 weeks. 
Rabbit BM-
MSC 
 
Engineered cartilage from 
autologous BM-MSC and PLGA 
scaffold filled the defects in the 
rabbit knees. The constructs were 
macroscopically and 
histologically similar to hyaline 
cartilage at 12 weeks post 
transplantation.  
PCL- Poly(carprolactone) 
(82) 3 porous 
PCL scaffold 
types 
investigated 
(1)PCL/Plur
onic F127, 
(2)PCL 
collagen and 
(3)PCL/Plur
onic 
F127/collag
en, in 
addition to 
(4) PCL only
In vitro; 3 porous PCL 
scaffold modifications 
investigated (1) 
PCL/Pluronic F127, 
(2) PCL collagen and 
(3) PCL/Pluronic 
F127/collagen, in 
addition to (4) PCL 
only. Cultured for 3 
weeks. 
Human BM-
MSC 
The 3 surface treated scaffolds 
had higher chondrospecific DNA 
content than the PCL only. GAG 
concentrations were also higher 
than in the PCL only, and RT-PCR 
showed that Sox 9 and Col IIA1 
were remarkably elevated in the 
modified PCLs. Notably, Col IA1 
and ColI0A1 mRNA levels were 
lower in the three modified 
scaffolds than in the PCL, 
suggestion prevention of the 
dedifferentiated phenotype.  
(95) Electrospun 
3D 
nanofibrous 
scaffold 
In vitro; MSC seeded 
onto pre-fabricated 
nanofibrous scaffold 
for 21 days 
Human BM-
MSC 
Histological analysis was 
congruent with cartilage 
formation when cells were grown 
in medium containing TGFǃ1. 
The cartilage specific gene profile 
(Aggrecan, Col II and Col X) was 
low, but improved significantly in 
chondrogenic medium with 
TGFǃ1. Col X levels were 
paradoxically down regulated. 
There was positive 
immunohistochemistry for 
cartilage specific ECM molecules.  
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PGA-Polyglycolic acid 
(158) Porous PGA 
and high 
density 
polyethylen
e composite 
scaffold 
In vivo; High-density 
polyethylene carved 
into cylindrical rods 
(internal support), 
with non-woven PGA 
sheets wrapped 
around the rods to 
form the scaffold. 
Implanted 
subcutaneously into 
nude mice. 
Porcine 
BMSC 
8 weeks post-implantation the 
constructs had formed mature 
cartilage with an abundant 
deposition of ECM on SEM. The 
experimental groups showed a 
positive histological likeness to 
cartilage with large number of 
lacunae and good expression of 
Col II.  
(157) PGA-HA 
composite 
scaffold 
In vivo; MSC were 
seeded onto the PGA-
HA and co-cultured 
for 72hours. There 
were then implanted 
into full thickness 
cartilage defects in 
the intercondylar 
fossa of rabbit femurs. 
Constructs were then 
harvested after 16 or 
32 weeks of surgery. 
Rabbit MSC Grossly, the constructs 
demonstrated hyaline cartilage 
formation and at 16 weeks, there 
appeared to be integration with 
surrounding normal cartilage and 
subchondral bone. At 32 weeks 
there was no sign of degradation 
of the neoconstruct.  
(160) PGA vs. 
PLA bio-
resorbable 
nonwoven 
scaffolds 
In vivo; Cells seeded 
onto scaffolds and 
cultured for 7 days in 
serum free media, 
before implantation 
into subcutaneous 
nude mice for 6 and 
12 weeks  
Human 
articular 
chondrocytes 
Aggrecan synthesis always higher 
in the PGA groups. mRNA gene 
expression for Col II significantly 
higher in the PGA groups after 6 
and 12 weeks. Expression of Col X 
and cartilage oligomeric matrix 
protein increased on both 
scaffolds.  
PEG- Poly (ethylene glycol) 
(125) PEG-
peptide 
copolymer 
gels 
In vitro; RGD and 
KLER sequences 
chosen as motifs to 
modify PEG gels. 
(KLER is a binding 
site from decorin 
protein, known to 
bind strongly to Col 
II, RGD promotes 
survival of 
encapsulated cells). 
Cells were 
encapsulated in the 
PEG peptide gel and 
cultured for 6weeks 
Human MSCs After 14 days, cells in RGD and 
KLER functionalized gels 
produced 2.5 times as much GAG 
as those only containing RGD. 
hMSCs also produced 27x as 
much hydroxyproline (a major 
component of collagen) than 
scrambled sequence gel controls. 
Col II was more prominent in 
KLER gels on immunostaining 
and RT-PCR analysis 
demonstrated higher levels of Col 
II and aggrecan synthesis.  
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(111) Hydrogel In vitro; cells were 
encapsulated in the 
PEG hydrogel and 
allowed to free swell 
for 24hrs.  
Bovine 
temporoman
d-ibular 
chondrocytes 
Condylar chondrocyte viability 
was maintained within the 
constructs during cell culture. 
RTPCR analysis showed the 
expression of cartilage specific 
markers, namely Col II, aggrecan 
and Col I was maintained 
Table 1. Summary of in vitro and in vivo studies that have used various scaffolds to engineer 
cartilage (2005-2010).  Abbreviations: AD-MSC, adipose derived mesenchymal stem cells. 
BMSC, bone marrow stromal cells. BM-MSC, bone marrow derived mesenchymal stem cells. 
Col, collagen. ECM, extra cellular matrix. GAG, glycosaminoglycan. Hbx, homeobox. Ihh, 
Indian hedgehog. OA, osteoarthritis. PTHrp, parathyroid hormone replacement hormone. 
RT-PCR, real-time polymerase chain reaction. SEM, scanning electron microscopy. sGAG, 
sulphated glycosaminoglycan 
Alginate: derived from brown marine algae and is consists of 1, 4-linked ǃ-D-mannuronnic 
and ǂ-L-guluronic residues, which are soluble in aqueous solutions. Cross-linking with 
bivalent cations such as Ba2+ or Ca2+ allows it to form stable gels.  
Chitin: a polysaccharide based analogue of GAG found in the exoskeleton of arthropods. 
Relatively unexplored bioactive scaffold for tissue engineering, perhaps because it is 
degraded in vivo by lysozyme; an enzyme found in many human bodily fluids.   
Collagen 1 and II: As the principle ECM components of cartilage, seeded chondrocytes can 
bind using inherent cell-surface receptors and use standard signalling pathways to regulate 
proliferation and growth. Can be fabricated as a sponge, foam, or gel, but like chitin, is 
subject to enzymatic breakdown. 
Fibrin: Can be derived from autologous blood samples, and has a comprehensive history of 
biocompatibility in its clinical use as a wound adhesive. Chondrocytes have integrins that 
can bind directly to fibrin, much like with collagen.  
Gelatin: A porous substance derived from hydrolysis of collagen. Its application as a scaffold 
for cartilage tissue engineering is relatively unchartered.  
Hyaluronic Acid: a non-sulphated GAG, found in abundantly within the cartilaginous ECM. 
It is crucial for maintaining the biophysical properties of the cartilage ECM for optimum 
chondrocyte growth and proliferation.  
4.2 Synthetic 
The main aim of biomimetic materials (synthetic biomaterials) is to generate 3D scaffolds 
that support essential cell functions in addition to mimicking the biomechanical properties 
of host tissues, whilst avoiding host immune responses (Table.1). These are two 
characteristics more difficult to find in natural scaffold alternatives. When considering 
clinical applications, susceptibility to vascular invasion is a key consideration and there is 
continued debate between groups about the need for biodegradation. Persistence and 
stability have been the focal aims for tissue engineering cartilage with the mechanical and 
biochemical properties of synthetic materials being more amenable to modification than 
natural scaffolds. 
Polyhydroxyacids: polyhydroxyacids such as PLLA [poly (L-lactic acid)], PCL [poly (L-
lactide-ε-caprolactone)] and PGA [poly (glycolic acid)] have been well studied as potential 
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cartilage scaffold matrices, where they are easily extruded into fibrous or open lattice 
sponges. PGA is reportedly highly biodegradable (5 weeks); PLLA can stay in vivo up to 3 
years. PCL and PGA used to fabricate ear templates for tissue engineering auricular 
cartilage (133).  
Elastomeric polyurethanes: Well documented history of use in a variety of biomedical 
instruments, ranging from urinary and vascular catheters to intra-aortic balloons and 
mammary implants. Can be fabricated in a biodegradable form, and have been shown to 
support chondrocyte attachment and growth.  
PEG [poly (ethylene glycol)]: FDA (Food and Drugs Administration) approved, and extensive 
research into its ability to promote chondrogenesis 
4.3 Regulatory influence of scaffolds on cell behaviour  
It is widely appreciated that soluble biochemicals such as cytokines, growth factors and 
chemokines affect the growth and development of all tissues including cartilage. 
Transforming growth factor beta (TGFǃ) and bone morphogenic proteins (BMPs) have been 
evidenced as highly potent stimulators of cartilage tissue generation (78; 96; 118). In 
addition to such signalling mechanisms, ECM proteins such as collagens, 
glycosaminoglycans and proteoglycans exert an array of instructions on cells via 
transmembrane receptors that affect expression and therefore, cell behaviour. Much of this 
instruction will crosstalk with growth factor signalling (37; 44). Additional studies have also 
shown chondrocytes to be particularly receptive to mechanical loading, with this parameter 
having been evidenced as a crucial factor in the chondrogenic differentiation of MSCs 
during critical cartilage development. Repetition of these loads and varying the duration 
and force of the load has positive effects on the structural organization of cartilage ECM (7; 
62). The effects of mechanobiology on chondrogenesis have been discussed in detail in the 
section on stem cells.  
In recent times, tissue engineering research had broadened its horizons to understand the 
effect of scaffold physical properties on cell behaviour. Properties considered include; 
roughness (88; 89; 147), micro and nanotopography (reviewed in (132)), porosity (155) and 
surface energy (80; 147). The stiffness of the substrate (scaffold matrix) has been 
demonstrated as a crucial regulator of stem cell behaviour (15; 48; 52; 119). It is thought that 
the stiffness or elasticity of a matrix can act as a ‘passive’ cue for cell processes via a 
phenomenon known as mechano-transduction. This is a method by which cells convert 
mechanical stimuli into a chemical response, thus affecting their own behaviour. For 
detailed reviews see (2; 54). Cells bind to the matrix using integrins. The intra cellular 
domain connects to the actin and myosin (contractile) cytoskeleton of the cell, and the 
extracellular domain to the biomaterial. When cells are bound, they apply mechanical forces 
onto the matrix using their contractile cytoskeleton. Integrins cluster which in turn recruits 
structural and signalling proteins at the site of contact between cell and matrix, known as a 
focal adhesion. If a matrix is relatively hard, there is more resistance to the forces applied by 
the cellular cytoskeleton. This results in a more organized cytoskeleton, more integrin 
clustering and thus focal adhesions that are greater in maturity. Comparatively, if cells are 
seeded onto a soft matrix, there is little resistance to counterbalance the cell forces, therefore 
reduced development of the actin-myosin cytoskeleton. This phenomenon is fundamental 
considering that changes in cytoskeletal organization affect signalling, thereby translating 
mechanical processes into chemical responses.  
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So how can this trend be used in cartilage tissue engineering technology? Let us consider the 
application of stem cells in tissue engineering cartilage. Stem cells extracted from human or 
animal sources are frequently expanded in culture. Culturing stem cells on traditional tissue 
culture plastic could result in preconditioning of the cells in accordance with the stiffness of 
the plate (51; 52). Depending on the experimental aims, it may be wiser to culture and 
expand on softer substrates with stiffness comparable to that of native tissue. However 
conflicting data has shown that stiffer substrates increase the rate of proliferation, whereas 
soft substrates promote the dedifferentiation of cells (15).This suggests the stiffness of the 
material used for cartilage tissue engineering is an important parameter not just in terms of 
mechanical support but also in terms of propagating chondrocyte growth and matrix 
deposition.  
4.4 Nanomaterials 
Cell coverage over a matrix layer is directly correlated to the spread of microscale ECM 
proteins over its surface, irrespective of the geometric patterning of such proteins (93). 
This theory applies at the microscale level of tissue engineering, but at the nanoscale, 
there is increasing evidence to indicate that cells are able to alter their behaviour 
differentially in response to changes in nanotopographical surfaces. These changes can be 
cytoskeletal or a change in morphology, focal adhesions, motility, gene expression and 
differentiation. Much like the mechano-transduction discussed earlier, there is support for 
some sort of topography-dependent transduction that communicates independent of 
chemical signalling from ECM molecules (35). Studies have since demonstrated that this 
cellular response is heavily related to the pattern and spacing of adhesive ligands 
(36;41;79;148).  
In light of the revelation that nanotopography plays a major role in the governance of cell-
matrix interactions, many physical and chemical methods have been developed to engineer 
geometrically defined nanopatterns on biocompatible scaffolds. Crude methods of acid 
treatment (85), bonding with calcium cations (63), and coating with nanoparticles (reviewed 
in (126)) allowed scientists to introduce nanofeatures into the surface topography of 
scaffolds. Surface modifications with Lanthanum phosphate (LaPO4) nanoparticles 
increased osteoblast adhesion to traditional bioceramics; Hydroxyapatite and Tricalcium 
phosphate (53). Likewise with chondrocytes, the levels of adhesion increased on 70%/30% 
(wt) PLGA/titanium composite scaffolds manufactured to have a nanosurface (76). 
However the advancement of nanoscience allows more precise pattering of various 
nanofeatures to further affect cell behaviour. Nanofeatures now come in many forms 
ranging from nanopits and grooves, to nanopillars, nanodots and traditional nanoparticles. 
The pattern in which they are arranged is also on the nanoscale. The latest techniques used 
for nanosurface pattering (reviewed in (132)) include photolithography, electron beam 
lithography (40), Dip-pen lithography (71) and imprint lithography.  
Nanopatterning to mimic the surface density and arrangement of integrin-binding epitopes 
as seen in the ECM has been a challenge not yet beaten. Studies have shown that integrin 
mediated signalling operates with a minimum surface density however; the exact spatial 
organization of these ligands in vivo has not been elucidated. The nearest estimate has come 
from a group that developed a block-copolymer micelle nanolithography technique to label 
surfaces with hexagonal arrays of gold nanodots coated with one RGD peptide (found in 
adhesive glycoproteins such as fibronectin and vitronectin) (26;27). Upon cell seeding they 
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found that only 28nm and 58nm spacing between the nanodots would allow adequate 
clustering of integrins, which are approximately 8-12nm in size (138). Additional studies on 
RGD-coated gold nanoparticles have shown that the velocity of migrating cells decreases 
with an increased particle density, with a peak velocity at circa 120nm, suggesting the boost 
in particle density increased levels of adhesion (6;65). Interestingly enough, research has also 
shown the MSC osteoblastic differentiation can be hampered by regularly arranged 
hexagonal nanopits arrays compared with arrays with a slight irregularity (39). Similar 
results were found by Biggs et al 2007, where highly ordered nanopits resulted in decreased 
formation and length of focal adhesions, compared with controlled disorder increasing focal 
adhesion formation and size (13).  
With more research being conducted into the in vitro effects of surface nanopatterning on 
cell behaviour, there are implications for cartilage tissue engineering research. Data shows 
that nanostructured PLGA can accelerate chondrocyte attachment, growth and proliferation 
in addition to improving ECM production (76). In our lab, chondrocytes seeded onto 
nanocomposite polymer POSS-PCU (UCL nanoBio™) have a faster rate of proliferation 
compared with controls lacking the nano modification (unpublished data). And though the 
current research into nanomaterials and cartilage tissue engineering is just evolving, there 
are many lessons to be learnt from bone (80;81), skin (31) and vascular (100;108) tissue 
engineering research.  
5. Bioreactors 
Bioreactors are devices in which biological and/or biochemical processes develop under 
controlled and monitored environmental and operating conditions (104). It is the 
exceptional control over environmental conditions that makes bioreactor use particularly 
pertinent in tissue engineering research where specific factors need to be controlled in order 
to optimise tissue growth. Bioreactors can maintain physiological boundaries at desired 
levels, enhance nutrient and waste transport rates, and provide specific stimuli to promote 
optimum growth.   
The use of bioreactors has provided a promising method for tackling some causes for poor 
research outcomes in tissue engineering practice. Restricted, unspecific, or impermanent cell 
differentiation and poor tissue formation/ remodelling in cartilage tissue engineering 
largely results from a lack of correct physical stimulation in vitro (86). For example, 
mechanotransduction, the transduction of mechanical stresses into biochemical signals, 
affects chondrocyte function. Modifying the mechanical stressors applied to cells in vitro may 
therefore improve the quality of tissue constructs produced. In early parts of this chapter, the 
effect of cyclical loading, especially within the articular region has been shown to improve the 
ECM content of constructs, and therefore the overall construct viability. Mimicking some of 
these forces in bioreactor systems could also dramatically improve tissue growth. Studies 
which evidenced the effect of adaptive physical stimulation on mechanotransduction, led to 
the development of bioreactor devices that transmit forces including shear stress, hydrostatic 
pressure and compression to articular cartilage in vitro (129). 
5.1 Mechanical forces 
Key to tissue engineering in the joint region specifically is the use of exogenous mechanical 
forces to simulate loading forces (exerted during daily movement and exercise), which in 
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turn increases the metabolic activity of and ECM production by chondrocytes. Shear stress, 
compressive forces, tensile forces and hydrostatic pressures are all parameters that can be 
modulated to influence the quality of cartilaginous constructs engineered. The effect of these 
mechanical forces on chondrogenesis, have been described earlier in the chapter. We will 
examine briefly the bioreactors that have been used to study the effects of shear stress 
however, the different types of bioreactors available for exerting other forces are expertly 
reviewed in Schulz RM 2007.  
 
 
Fd 
Fc 
Fg 
ROTATING 
VESSEL 
STIRRED 
VESSEL 
STATIC 
VESSEL 
 
Fig. 4. Experimental appraoches to bioreactor tissue engineering. Representation of static, 
stirred and rotating vessels. Fc, Fd, Fg refer to centrifugal, drag and net forces respectively. 
(Adapted from Vunjak-Novakovic G 1999 (145)) 
The easiest method for examining the effects of shear stress in bioreactor systems is by 
placing constructs in culture either on a petri dish or in a dynamic or orbital shaker (56;57). 
Other methods developed have included using spinner flasks or vessels with magnetic 
stirrers (14;18;136). Extensive study in the nineties looked at the application of shear stress 
by comparing static and orbital shakers, stirred vessels with rotating vessels (Fig.4) (145). 
Rotating vessels are more advanced systems where constructs float freely within culture 
medium, whilst the whole vessel rotates around a central axis at a constants speed. 
Chondrocytes were seeded onto 97% porous scaffold discs and cultured in the 
aforementioned vessels for 8 weeks. Results showed that freely cultured constructs were 
larger than those cultured in static or stirred vessels. They formed cartilaginous ECM with 
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the greatest concentration of GAGs and collagen. Their mechanical properties where also 
shown to be superior.   
5.2 Oxygen tension 
Optimizing O2 tension within culture systems is an area of great importance in bioreactor 
design. O2 is the partial pressure of oxygen dissolved in a liquid such as blood.  Cells in 
culture require nutrients and oxygen to proliferate and this is usually achieved through 
mass transport (net movement of mass from one location to another). When oxygen and 
nutrients are limiting factors, larger grafts tend to contain a hypoxic, necrotic centre, 
surrounded by a rim of viable cells (Martin I 2004). In a tissue graft, the density of cells may 
be higher than the distance oxygen can freely diffuse across by mass transport to provide 
sufficient oxygen for the inner cells; therefore they are starved of oxygen. Limited O2 
diffusion can also affect the spatial distribution of cells and as the O2 concentration gradient 
decreases from the surface of the tissue compartment to its centre (34). In humans, this 
problem is solved by the circulatory system and thus nutrients are provided to all cells via a 
complex network of vessels, slowly decreasing in size the deeper into tissues they enter. It is 
the proximity of capillaries to somatic (body) cells that allows their mass transfer 
requirements to be met (105). So how is this problem solved in tissue engineering practice? 
The introduction of simple stirred flask bioreactors enables the mixing of oxygen and 
nutrients throughout the medium. So not only does it provide a shear stress which is known 
to be beneficial for chondrocyte growth and proliferation, but it also reduces the 
concentration boundary layer of oxygen at the construct surface (14;18;104). In a static 
culture environment, oxygen would diffuse into cells and carbon dioxide out. The medium 
in closest proximity to the cells would have a steadily decreasing O2 tension with a 
conversely increasing CO2 tension. This in turn limits the overall rate diffusion as O2 moves 
from areas of high tension to areas of low tension. Thus if the culture medium is not 
circulated or replenished the rate of diffusion will decrease and eventually cease at the point 
where there is no longer a concentration gradient, leading to cell death.  
Studies have also used bioreactors to investigate the effect of different partial pressures of 
O2 and pH levels on gene and protein expression, as well as the metabolic activity of 
chondrocytes. Results showed chondrocyte sensitivity to acidic conditions where reduced 
expression of Coll Type 1, SOX9 and VEGF (vascular endothelial growth factor) were 
observed. Conversely in hypoxic conditions, VEGF levels were found to be higher, with a 
pH dependent reduction in Coll Type 1 (43). Culture in bioreactors at low oxygen tension 
increases the production and retention of glycosaminoglycan (GAG) within the cartilage 
matrix without affecting chondrocyte proliferation or collagen deposition which typically 
would requires higher partial pressures of O2 (123). These studies highlight the twofold 
applications of bioreactors, in maximizing cell growth and tissue generation for clinical use 
and in research and development to investigate the effect of different biological factors on 
cell growth.  
5.3 Growth factors 
It has also bee suggested that bioreactors provide suitable environments to add growth 
stimulating factors to constructs to improve chondrogenesis. For example, transducing 
human MSCs with an adenoviral vector containing SOX9 and subjecting the construct to 
mechanical stimulation could increase GAG synthesis (90). Growth factor application of 
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BMP-2, IGF-1 and TGF-ǃ1 in a bioreactor system can increase the compressive and tensile 
biomechanical properties of engineered tissue (50). The efficiency of chondrocyte 
proliferation from low initial seeding densities can also be enhanced by adding various 
growth factor combinations in to automated bioreactors systems (55). Chitosan scaffolds 
were used to engineer articular cartilage with the aid of a chondrogenic differentiation 
factor, BMP-6. Results showed that proliferated cells contained a higher value of GAG, Coll 
type II and DNA indicating improved chondrogenesis (1). Alternatively, inhibiting the 
expression of some factors, namely interleukin 6, has also been investigated with the aim of 
improving tissue growth in bioreactors. In 2010, Wang P et al demonstrated how high levels 
of interleukin – 6 have been found in osteoarthritic cartilage and suggested that inhibiting 
this expression may improve cartilage construct culturing in bioreactors (146).  
6. Challenges for the clinical application of regenerated cartilage 
Over the past two decades the amount of data on cartilage tissue engineering strategies has 
risen exponentially. There is now a plethora of exciting in vitro data evaluating 
chondrocyte/MSC seeded biomaterial constructs. Perhaps one of the most iconic studies in 
cartilage tissue engineering research was produced by Cao and Vacanti’s group in 1996, 
when they implanted an auricular shaped cartilaginous construct onto the back of a mouse 
(24). Even with all the advancements in stem cell and biomaterial technology, the invention 
of various bioreactor systems, little has progressed beyond this scientifically historic event. 
Most constructs fail to develop beyond immature, inflexible neocartilage that lacks the 
durability essential to most clinical applications.  
There are a number of reasons for the stagnation in translation to clinical practice. Many of 
which have been discussed throughout the course of this chapter. On a cellular level, 
reasons for poor research outcomes could also include;  (i)Regenerative cells being lost 
through leakage of the cell suspension (149), (ii) inflammatory cytokine, matrix 
metalloproteinase, nitric oxide mediated apoptosis and necrosis at the site of injury. These 
biochemical factors are released as part of the normal inflammatory and wound healing 
process, especially at the interface between host and repair tissue, which can also adversely 
affect biointegration of the neo tissue. The use of anti-apoptotic factors would be crucial in 
maintaining cell numbers but also in creating a favourable environment for biointegration 
(5). The poor migration capacity of chondrocytes could also be responsible for hampered 
infiltration of repair tissue into the host environment. The naturally slow rates of 
chondrocyte ECM production could slow down integration as well disparities in the 
organization of neocartilage matrix compared with the zonal arrangement of native cartilage 
tissue (69;84).  Dedifferentiation of chondrogenic cells is another problem, and is likely 
responsible to the highly fibrotic nature of neocartilage produced, suggesting that over time, 
cells may have dedifferentiated into fibroblasts or incompletely differentiated into 
chondrocytes. Solutions would include seeding with cells that have been fully differentiated 
in vitro, but again there would be difficulties with motility, proliferation and shelf life.  
In addition to the cell based scientific problems associated with cartilage engineering tissue 
research, ambiguous regulatory guidelines currently hamper the flow of development from 
laboratories to clinics and operating theatres. The EU regulation on Advanced Therapy 
Medicinal Products (ATMP), which includes tissue engineered constructs, is still in its 
infancy having only been formally established in December 2008. ATMP regulation aims to 
proved a coherent and tailored framework for tissue engineered products, however the 
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nascent and fast growing nature of the tissue engineering field means that there is a constant 
threat of irrelevance over the guidelines developed under this regulation. Tissue 
engineering technology needs to reach a level of quality controlled and quality assured 
reproducibility to allow for not just clinical efficiency, but also commercial viability. 
Methods of stem cell differentiation, cell seeding, scaffold fabrication and bioreactor 
development/implementation all need to be governed by Good Manufacturing Practice 
(GMP). Additionally, methods of commercialization ought to be better established, to avoid 
uncertainty in the markets, improve regulatory approval and clinical uptake/use (103).  
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